genedrive plc (LON:GDR – Get Free Report) rose 14.3% during trading on Thursday . The stock traded as high as GBX 1.20 and last traded at GBX 1.20. Approximately 2,583,513 shares traded hands during mid-day trading, a decline of 58% from the average session volume of 6,164,894 shares. The stock had previously closed at GBX 1.05.
genedrive Stock Performance
The stock’s fifty day simple moving average is GBX 1.22 and its 200-day simple moving average is GBX 1.08. The company has a market capitalization of £17.34 million, a PE ratio of -1.37 and a beta of 0.99. The company has a quick ratio of 5.52, a current ratio of 0.99 and a debt-to-equity ratio of -120.48.
About genedrive
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.
Recommended Stories
- Five stocks we like better than genedrive
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
- MarketBeat Week in Review – 07/13- 07/17
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
